US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,369.95

+5.240.38%

Number of Gainers:10

Number of Losers:10

Number of Flat:- -

PE:- -

High:1,380.29

Open:1,364.76

Low:1,358.78

Close:1,364.65

Loading ...

Equillium Inc - Receives FDA Feedback on Itolizumab for Agvhd

THOMSON REUTERS

Equillium Inc - FDA Declines Breakthrough Therapy Designation for Itolizumab

THOMSON REUTERS

3 Healthcare Stocks Facing Headwinds

With 67% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns

Simply Wall St.

Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump

Equillium Announces Feedback from the U.S. Food and Drug Administration

Moderna’s Financial Outlook Dims: Revenue Projections and Diversification Challenges Lead to Sell Rating

BRIEF-Guardant Health Announces Strategic Collaboration With Pfizer To Support Development And Commercialization Of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform

BioNTech to Showcase Oncology Advances at AACR 2025

Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform

THOMSON REUTERS

Guardant Health Inc - Collaboration Provides Pfizer Access to Guardant Tests in China

THOMSON REUTERS

Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform

2 No-Brainer Stocks to Buy With Less Than $30

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?

Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?

Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying

Pfizer Declares Second-Quarter 2025 Dividend

THOMSON REUTERS

Pfizer - Quarterly Cash Dividend of $0.43 per Share

THOMSON REUTERS

Press Release: Pfizer Declares Second-Quarter 2025 Dividend

Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1369.8882,"timestamp":1746035861699,"preClose":1364.6454,"halted":0,"volume":55189957,"delay":0,"changeRate":0.003842,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":5.242798,"latestTime":"04-30 13:57:42 EDT","open":1364.7573,"high":1380.285,"low":1358.7754,"amount":2308886292.89505,"amplitude":0.015762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.640146,"peRate":22.008402,"turnoverRate":0.003559,"increases":10,"decrements":10,"flats":0,"marketCap":1131360646288,"floatMarketCap":1111516529442},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1380.285,"amplitude":0.015762,"preClose":1364.6454,"low":1358.7754,"pbRate":"3.640146","latestPrice":1369.9508,"volume":55186506,"delay":0,"open":1364.7573,"prevYearClose":1274.8187,"prevWeekClose":1341.1263,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1344.1606,"twentyDayClose":1377.6108,"sixtyDayClose":1350.7439,"secType":"PLATE","market":"US","turnoverRate":0.003559,"peRate":22.008402,"marketCap":1131358008464,"floatMarketCap":1111513940770,"timestamp":1746035858669,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":10,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529980168","title":"Equillium Inc - Receives FDA Feedback on Itolizumab for Agvhd","url":"https://stock-news.laohu8.com/highlight/detail?id=2529980168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529980168?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:06","pubTimestamp":1745499998,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nFWN3R236L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2529169980","title":"Equillium Inc - FDA Declines Breakthrough Therapy Designation for Itolizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2529169980","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529169980?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:06","pubTimestamp":1745499998,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nFWN3R236L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2529958462","title":"3 Healthcare Stocks Facing Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2529958462","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529958462?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:02","pubTimestamp":1745499755,"startTime":"0","endTime":"0","summary":"From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 12.7%. This drop was worse than the S&P 500’s 7.5% loss.While some businesses have durable competitive advantages that enable them to grow consistently, the odds aren’t great for the ones we’re analyzing today. Keeping that in mind, here are three healthcare stocks that may face trouble.Rising to global prominence during the COVID-19 pandemic with one of the first effective vaccines, Moderna  develops messenger RNA  medicines that direct the body's cells to produce proteins with therapeutic or preventive benefits for various diseases.Sales tumbled by 59% annually over the last two years, showing market trends are working against its favor during this cycle. Free cash flow margin dropped by 369.1 percentage points over the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-healthcare-stocks-facing-headwinds-130235323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","BK4501","LU0006061336.USD","ZBH","LU0708994859.HKD","LU0029864427.USD","BK4504","IE00B64QTZ34.USD","LU1267930490.SGD","LU1267930573.SGD","LU1267930813.SGD","BK4548","BK4532","LU0792757196.USD","BK4139","LU0211328371.USD","BK4568","LU0310800379.SGD","HCSG","LU0310799852.SGD","MRNA","IE0002270589.USD","IE00B19Z6F94.USD","LU0128525929.USD","BK4585","BK4551","IE00B19Z3581.USD","BK4588","IE00B19Z3B42.SGD","BK4566","IE0034390439.USD","IE00B7SZLL34.SGD","LU0211327993.USD","BK4082","BK4121","TECH","BK4533","LU0889566641.SGD","BK4534"],"gpt_icon":0},{"id":"2529895584","title":"With 67% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns","url":"https://stock-news.laohu8.com/highlight/detail?id=2529895584","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529895584?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:00","pubTimestamp":1745499612,"startTime":"0","endTime":"0","summary":"Institutions' substantial holdings in Pfizer implies that they have significant influence over the company's share price. 43% of the business is held by the top 25 shareholders. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.To get a sense of who is truly in control of Pfizer Inc. , it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 67% to be precise, is institutions. That is, the group stands to benefit the most if the stock rises .Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait.Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/67-institutional-ownership-pfizer-inc-130012784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0306807586.USD","BK4592","LU0058720904.USD","LU1894683348.USD","LU0122379950.USD","LU0234572021.USD","LU1066053197.SGD","LU1023059063.AUD","SG9999001176.SGD","SGXZ57979304.SGD","LU1066051498.USD","SG9999002224.SGD","SG9999002232.USD","IE00BLSP4452.SGD","SG9999013999.USD","LU0985481810.HKD","LU0225771236.USD","BK4568","PFE","BK4581","LU1057294990.SGD","IE0002270589.USD","SG9999001176.USD","BK4585","LU0170899867.USD","IE00BBT3K403.USD","LU1883839398.USD","IE00B19Z3581.USD","BK4007","LU0225284248.USD","LU0289739699.SGD","BK4588","LU0456855351.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","NYSE","IE00BLSP4239.USD","LU0321505868.SGD","SG9999003800.SGD","LU0321505439.SGD","LU0306806265.USD","SG9999011175.SGD","BK4550","BK4533","LU1894683264.USD","IE000M9KFDE8.USD","BK4534","BK4599"],"gpt_icon":1},{"id":"2529760934","title":"Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump","url":"https://stock-news.laohu8.com/highlight/detail?id=2529760934","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529760934?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:00","pubTimestamp":1745499600,"startTime":"0","endTime":"0","summary":"GALWAY, Ireland, April 24, 2025 /PRNewswire/ -- Medtronicplc , a global leader in healthcare technology, today announced it has submitted 510 applications to the U.S. Food and Drug Administration  seeking clearance for an interoperable pump. FDA clearance of this pump would pave the way for system integration with a continuous glucose monitoring  sensor based on Abbott's most advanced CGM platform.About MedtronicBold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and mor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/medtronic-advances-abbott-cgm-partnership-130000878.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medtronic-advances-abbott-cgm-partnership-130000878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211326839.USD","LU1989763427.SGD","IE00BQXX3D17.EUR","LU1291159041.SGD","LU1116320737.USD","SGXZ23171101.USD","LU0976567544.SGD","IE00BQXX3F31.USD","LU1989764664.SGD","LU1057294990.SGD","BK4568","LU2237957811.SGD","LU2111349929.HKD","LU0170899867.USD","LU2112291526.USD","LU0265550359.USD","BK4585","ABT","LU2028103732.USD","LU2133065610.SGD","LU2023251221.USD","MDT","IE00BFXG1179.USD","BK4504","LU0070302665.USD","LU2089283258.USD","LU0162691827.USD","BK4592","IE00B2B36J28.USD","LU0234572021.USD","LU0266013472.USD","LU2468319806.SGD","LU0496365809.HKD","BK4588","LU1023059063.AUD","LU0265550946.USD","LU0868494617.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","SG9999004303.SGD","LU1914381329.SGD","LU0208291251.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU2089284900.SGD","LU0211331839.USD","LU1061106388.HKD","BK4581","LU1571399168.USD","IE00BQXX3C00.GBP"],"gpt_icon":0},{"id":"2529354759","title":"Equillium Announces Feedback from the U.S. Food and Drug Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2529354759","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529354759?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:00","pubTimestamp":1745499600,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., April 24, 2025----Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that the company has received feedback from its Type D meeting with the U.S. Food and Drug Administration  to discuss the regulatory pathway for Accelerated Approval, as well as the company’s filing for Breakthrough Therapy designation for itolizumab for first-line treatment of acute graft-versus-host disease .The FDA declined to grant Breakthrough Therapy designation or support an Accelerated Approval pathway based on the EQUATOR study data. The FDA highlighted its attention to achieving response outcomes at Day 29, per existing FDA guidance; however, the FDA did indicate openness to evaluating other endpoints, including longer term outcomes, provided independent data supports the validity of such endpoints.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/equillium-announces-feedback-u-food-130000296.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2529298724","title":"Moderna’s Financial Outlook Dims: Revenue Projections and Diversification Challenges Lead to Sell Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2529298724","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529298724?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:57","pubTimestamp":1745499430,"startTime":"0","endTime":"0","summary":"In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Moderna (MRNA – Research Report), with a price...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/modernas-financial-outlook-dims-revenue-projections-and-diversification-challenges-lead-to-sell-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/modernas-financial-outlook-dims-revenue-projections-and-diversification-challenges-lead-to-sell-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BLSP4239.USD","BK4559","LU0128525689.USD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU1201861249.SGD","LU1668664300.SGD","LU1496350502.SGD","LU0130102774.USD","BK4553","LU0052756011.USD","BK4548","LU0208291251.USD","LU1880398554.USD","IE0002270589.USD","LU0640476718.USD","LU1363072403.SGD","BK4551","LU2129689431.USD","IE00BBT3K403.USD","LU0053666078.USD","LU0170899867.USD","LU0256863811.USD","LU0971096721.USD","LU1718418525.SGD","LU1280957306.USD","MRNA","IE00BFXG1179.USD","BK4585","BK4532","IE00BLSP4452.SGD","LU0098860793.USD","LU1162221912.USD","LU2133065610.SGD","LU0477156797.USD","LU0648001328.SGD","LU0130518102.USD","LU2129689514.USD","BK4501","BK4568","LU0868494617.USD","LU0320765646.SGD","BK4533","BK4207","LU1506573853.SGD","LU1883839398.USD","LU0310800965.SGD","LU0149725797.USD","LU0683600562.USD"],"gpt_icon":0},{"id":"2529989994","title":"BRIEF-Guardant Health Announces Strategic Collaboration With Pfizer To Support Development And Commercialization Of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2529989994","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529989994?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:15","pubTimestamp":1745496958,"startTime":"0","endTime":"0","summary":"BRIEF-Guardant Health Announces Strategic Collaboration With Pfizer To Support Development And Commercialization Of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy PlatformApril 24 (R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA6WCMJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","IE00BBT3K403.USD","LU0306807586.USD","BK4550","GH","IE0002270589.USD","SG9999001176.USD","LU1894683264.USD","BK4599","BK4535","LU1057294990.SGD","BK4568","SG9999013999.USD","BK4534","LU0170899867.USD","LU0122379950.USD","LU0225284248.USD","LU0306806265.USD","SG9999011175.SGD","PFE","BK4585","IE00B19Z3B42.SGD","LU0985481810.HKD","LU0058720904.USD","LU0321505439.SGD","IE00B19Z3581.USD","BK4007","LU0321505868.SGD","LU1066053197.SGD","SG9999003800.SGD","BK4592","LU1883839398.USD","LU0289739699.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0234572021.USD","BK4533","IE00BLSP4239.USD","LU0456855351.SGD","BK4588","LU1023059063.AUD","LU0868494617.USD","SG9999001176.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU1066051498.USD","LU0225771236.USD","LU1894683348.USD","IE000M9KFDE8.USD","BK4581"],"gpt_icon":1},{"id":"2529989252","title":"BioNTech to Showcase Oncology Advances at AACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529989252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529989252?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:15","pubTimestamp":1745496951,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BioNTech SE ( ($BNTX) ). On April 24, 2025, BioNTech SE announced its participation in the AACR Annual Meeting ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biontech-to-showcase-oncology-advances-at-aacr-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biontech-to-showcase-oncology-advances-at-aacr-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","BK4588","BNTX","BK4551","BK4535","BK4568","BK4548"],"gpt_icon":0},{"id":"2529986678","title":"Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2529986678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529986678?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:05","pubTimestamp":1745496300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA6WCMJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE000M9KFDE8.USD","LU0234572021.USD","LU1066051498.USD","GH","LU0225284248.USD","BK4535","IE00BLSP4452.SGD","BK4592","LU0170899867.USD","SG9999003800.SGD","SG9999001176.SGD","LU1057294990.SGD","LU1894683348.USD","LU0058720904.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4599","IE0002270589.USD","LU1066053197.SGD","LU0306807586.USD","SG9999002224.SGD","SG9999001176.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4533","BK4550","PFE","SG9999013999.USD","BK4007","LU1894683264.USD","BK4551","LU0122379950.USD","LU0306806265.USD","BK4534","LU1883839398.USD","BK4196","LU0289739699.SGD","LU0868494617.USD","LU0321505439.SGD","LU0321505868.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4585","BK4581","LU0225771236.USD","BK4588","LU0985481810.HKD","BK4568","SG9999002232.USD"],"gpt_icon":0},{"id":"2529398697","title":"Guardant Health Inc - Collaboration Provides Pfizer Access to Guardant Tests in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2529398697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529398697?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:05","pubTimestamp":1745496300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA6WCMJD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999002232.USD","BK4535","IE000M9KFDE8.USD","BK4196","LU0868494617.USD","LU1894683264.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","BK4568","LU0234572021.USD","LU1057294990.SGD","BK4534","PFE","BK4551","IE00B19Z3581.USD","LU0058720904.USD","LU0456855351.SGD","SG9999002224.SGD","BK4599","LU0289739699.SGD","BK4007","LU0985481810.HKD","SG9999011175.SGD","SG9999013999.USD","LU0170899867.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","GH","BK4588","BK4585","LU0122379950.USD","LU0306807586.USD","IE0002270589.USD","BK4533","BK4581","LU1023059063.AUD","BK4592","IE00BBT3K403.USD","LU0306806265.USD","SG9999001176.SGD","LU0225284248.USD","LU1066053197.SGD","LU1066051498.USD","SG9999003800.SGD","SG9999001176.USD","LU0225771236.USD","LU1894683348.USD","BK4550"],"gpt_icon":0},{"id":"2529982375","title":"Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2529982375","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529982375?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:05","pubTimestamp":1745496300,"startTime":"0","endTime":"0","summary":"Multi-year global collaboration will utilize Guardant liquid biopsy portfolio in research and clinical applications and evaluate utility of ctDNA for monitoring therapy response. PALO ALTO, Calif., April 24, 2025----Guardant Health, Inc. , a leading precision oncology company, today announced a strategic collaboration with Pfizer, Inc. , to support the development and commercialization of Pfizer’s oncology portfolio using the Guardant Infinity smart liquid biopsy platform.Under the multi-year collaboration agreement, Guardant and Pfizer aim to:. Utilize Guardant’s portfolio of liquid biopsy tests in Pfizer’s global clinical studies","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/guardant-health-announces-strategic-collaboration-120500219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0306806265.USD","SG9999002232.USD","BK4592","BK4534","BK4196","LU0985481810.HKD","LU1883839398.USD","LU1057294990.SGD","BK4581","LU1023059063.AUD","LU0456855351.SGD","SGXZ57979304.SGD","BK4585","GH","IE00B19Z3581.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU0170899867.USD","LU1894683264.USD","SG9999001176.SGD","BK4533","IE00B19Z3B42.SGD","IE00BLSP4239.USD","IE00BBT3K403.USD","BK4599","SG9999001176.USD","SG9999002224.SGD","LU0122379950.USD","BK4007","LU0225771236.USD","LU0321505868.SGD","LU1066051498.USD","LU0225284248.USD","BK4535","SG9999013999.USD","BK4568","LU1066053197.SGD","PFE","LU0868494617.USD","LU0234572021.USD","BK4551","BK4588","IE00BLSP4452.SGD","SG9999003800.SGD","LU0321505439.SGD","BK4550","LU0306807586.USD","IE000M9KFDE8.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2529797601","title":"2 No-Brainer Stocks to Buy With Less Than $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2529797601","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529797601?lang=en_us&edition=fundamental","pubTime":"2025-04-24 18:45","pubTimestamp":1745491500,"startTime":"0","endTime":"0","summary":"Pfizer's financial results are improving, and its pipeline should deliver substantial wins.Having significant capital in the bank when investing in equities is helpful, but is by no means necessary. Even with a relatively modest sum, like $30, it's possible to acquire one whole share of a top corporation that's likely to perform well in the long run. If you're patient and hold on to it through the kind of market volatility we're experiencing, while occasionally purchasing more shares, that should result in excellent returns.Which stocks trading for less than $30 per share are worth investing in today?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/24/2-no-brainer-stocks-to-buy-with-less-than-30/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0321505439.SGD","BK4534","IE0002270589.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0225771236.USD","LU1057294990.SGD","LU0868494617.USD","LU0058720904.USD","LU0225284248.USD","BK4585","LU1066051498.USD","SG9999003800.SGD","BK4550","IE000M9KFDE8.USD","LU1883839398.USD","SG9999013999.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0985481810.HKD","LU0306807586.USD","BK4599","IE00BLSP4239.USD","LU0306806265.USD","LU0122379950.USD","BK4007","LU0289739699.SGD","BK4588","LU0456855351.SGD","LU1894683348.USD","BK4592","LU1894683264.USD","SG9999001176.SGD","BK4533","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BK4568","LU1023059063.AUD","LU0170899867.USD","PFE","SG9999001176.USD","LU0234572021.USD","SG9999002224.SGD","LU0321505868.SGD","BK4581","SG9999011175.SGD"],"gpt_icon":1},{"id":"2529676383","title":"Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529676383","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529676383?lang=en_us&edition=fundamental","pubTime":"2025-04-24 16:51","pubTimestamp":1745484660,"startTime":"0","endTime":"0","summary":"Dow's steep stock decline has boosted its dividend yield significantly.Going against the grain often works in investing. Several of the most successful investors are contrarians by nature. One popular investing strategy -- the \"Dogs of the Dow\" -- focuses on buying the 10 stocks in the Dow Jones Industrial Average  with the highest dividend yields. The \"Dogs\" in the strategy's name reflects the fact that the stocks with the highest yields tend to be laggards.This general approach doesn't have to be limited to the Dow, though. And it doesn't have to include 10 stocks, either. Should you buy the three highest-paying dividend stocks in the S&P 500 ?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/24/should-you-buy-the-3-highest-paying-dividend-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00BMG7P819.SGD","VOO","IE00BMG7P926.USD","IE00BBT3K403.USD","SDS","SG9999011175.SGD","US7Y.BOND","IE00BMG7P587.USD","LU0868494617.USD","BK4504","BK4568","LU1057294990.SGD","US6M.BOND","SSO","PEG","BK4533","US3Y.BOND","IE00BD4GTW91.USD","SG9999001176.SGD","LU0170899867.USD","LU0234572021.USD","OEF","US12M.BOND","IE00BMG7P694.USD","US10Y.BOND","LU0321505868.SGD","US5Y.BOND","BK4559",".SPX","BK4599","LU0225771236.USD","LU1883839398.USD","BK4534","SPXU","BK4588","IE00BLSP4452.SGD","SGXZ57979304.SGD","BK4592","ESmain","LU0306807586.USD","IE00BLSP4239.USD","IVV","US2Y.BOND","SH","OEX","SG9999002224.SGD","US30Y.BOND","SPY"],"gpt_icon":1},{"id":"2529249726","title":"Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529249726","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529249726?lang=en_us&edition=fundamental","pubTime":"2025-04-24 13:48","pubTimestamp":1745473680,"startTime":"0","endTime":"0","summary":"Novavax NVAX shares rallied 19.5% in the last trading session to close at $7.47. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 17.3% loss over the past four weeks.The rise in share price comes after the vaccine-maker announced that the FDA has requested additional data on its protein-based COVID-19 vaccine as part of a post-marketing commitment. Although this signals a delay in full approval, investors took the news as a positive sign that the regulatory process is progressing and that the vaccine remains on track for eventual full approval.This vaccine maker is expected to post quarterly earnings of $0.19 per share in its upcoming report, which represents a year-over-year change of +118.1%. Revenues are expected to be $71.84 million, down 23.5% from the year-ago quarter.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novavax-nvax-surges-19-5-054800239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4548","BK4568","BNTX","NVAX","BK4551","BK4535","BK4547","BK4139","BK4585"],"gpt_icon":0},{"id":"2529336618","title":"Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2529336618","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529336618?lang=en_us&edition=fundamental","pubTime":"2025-04-24 08:48","pubTimestamp":1745455715,"startTime":"0","endTime":"0","summary":"We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at where Viking Therapeutics, Inc.  stands against other takeover rumor stocks hedge funds are buying.Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market. And what more could ignite such a frenzy of activity other than whispers of potential takeovers?When combined with subtle market signals and insider movements, these rumors can cause investors to purchase the stock. Income-seeking investors usually keep a close eye on such signs and movements to capitalize on emerging opportunities.READ ALSO:10 Dividend Paying Stocks Insiders Are Buying. In particular, hedge fund managers, using their vast resources and analytical capabilities, are more receptive to such speculative cues and act upon them. Since investors and the rest of the market tend to generate income by closely following their actions, hedge funds hold influen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-inc-vktx-among-004835769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","QLD","LU1057294990.SGD","LU0985481810.HKD","LU0058720904.USD","NVIW.SI","USJW.SI","LU0868494617.USD","MNQmain","VKTX","SG9999001176.SGD","BK4592","BK4534","LU1894683264.USD","BK4568","NQmain","LU0321505868.SGD","BK4588","BK4007","IE00B19Z3581.USD","SG9999002232.USD","LU0234572021.USD","TQQQ","BK4599","IE00BBT3K403.USD","LU1894683348.USD","LU0170899867.USD","SG9999001176.USD","IE000M9KFDE8.USD","SG9999002224.SGD","BK4581","BK4585","IE00BLSP4452.SGD","BK4533","LU0306807586.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU1023059063.AUD","TSYW.SI","QID","LU0306806265.USD","USAW.SI","LU0122379950.USD","LU0456855351.SGD","PSQ","SG9999003800.SGD",".IXIC"],"gpt_icon":1},{"id":"2529663917","title":"Pfizer Declares Second-Quarter 2025 Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663917?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:40","pubTimestamp":1745440800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nTUA3MNWBD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","LU0225771236.USD","BK4585","LU0234572021.USD","LU0321505868.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","LU0170899867.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0058720904.USD","BK4007","BK4533","LU0306806265.USD","LU1023059063.AUD","SG9999011175.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","LU1066053197.SGD","LU0122379950.USD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","IE0002270589.USD","SG9999001176.USD","LU0289739699.SGD","LU1883839398.USD","SG9999003800.SGD","BK4599","IE00B19Z3581.USD","BK4550","BK4588","LU0456855351.SGD","PFE","BK4581","SG9999013999.USD","LU1066051498.USD","LU0321505439.SGD","LU1894683348.USD","BK4592","BK4534","LU0306807586.USD","LU1057294990.SGD","SG9999002232.USD","LU0225284248.USD","SG9999001176.SGD"],"gpt_icon":0},{"id":"2529663468","title":"Pfizer - Quarterly Cash Dividend of $0.43 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663468?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:40","pubTimestamp":1745440800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nTUA3MNWBD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4550","LU0225284248.USD","LU0456855351.SGD","LU0306806265.USD","SG9999011175.SGD","IE00BBT3K403.USD","SG9999013999.USD","SGXZ57979304.SGD","SG9999003800.SGD","LU1883839398.USD","LU1894683264.USD","LU0289739699.SGD","LU0234572021.USD","BK4568","SG9999002232.USD","LU0306807586.USD","IE00BLSP4239.USD","BK4588","LU1023059063.AUD","PFE","BK4592","SG9999001176.SGD","LU0321505439.SGD","BK4585","LU1894683348.USD","LU0170899867.USD","BK4599","IE0002270589.USD","BK4533","LU0122379950.USD","IE00B19Z3B42.SGD","SG9999001176.USD","SG9999002224.SGD","LU1057294990.SGD","LU0058720904.USD","BK4534","LU0225771236.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU1066053197.SGD","BK4007","IE00BLSP4452.SGD","LU0868494617.USD","LU1066051498.USD","LU0985481810.HKD","LU0321505868.SGD","BK4581"],"gpt_icon":0},{"id":"2529663458","title":"Press Release: Pfizer Declares Second-Quarter 2025 Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663458?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:40","pubTimestamp":1745440800,"startTime":"0","endTime":"0","summary":"Board of Directors approves quarterly cash dividend of $0.43 per share. Pfizer Inc.  today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the company's common stock, payable June 13, 2025, to holders of the Common Stock of record at the close of business on May 9, 2025. The second-quarter 2025 cash dividend will be the 346th consecutive quarterly dividend paid by Pfizer.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0234572021.USD","LU1066051498.USD","LU0225284248.USD","LU0456855351.SGD","IE00BLSP4452.SGD","BK4592","LU0170899867.USD","SG9999003800.SGD","SG9999001176.SGD","LU1057294990.SGD","LU1894683348.USD","LU0058720904.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4599","IE0002270589.USD","LU1066053197.SGD","LU0306807586.USD","SG9999002224.SGD","SG9999001176.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4533","BK4550","PFE","SG9999013999.USD","BK4007","LU1894683264.USD","LU0122379950.USD","LU0306806265.USD","BK4534","LU1883839398.USD","LU0289739699.SGD","LU0868494617.USD","LU0321505439.SGD","LU0321505868.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4585","BK4581","LU0225771236.USD","BK4588","LU0985481810.HKD","BK4568","SG9999002232.USD"],"gpt_icon":1},{"id":"2529668948","title":"Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529668948","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529668948?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:08","pubTimestamp":1745438880,"startTime":"0","endTime":"0","summary":"Data from Cohorts 1-3 of trial to be presented in an oral session and poster at theSociety for Investigative Dermatology  2025 Annual Meeting. Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for 4:30 pm ET / 1:30 pm PT on May 8, 2025. SOUTH SAN FRANCISCO, Calif., April 23, 2025  -- Corvus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis will be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual Meeting, which is taking place May 7-10, 2025 in San Diego, CA.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corvus-pharmaceuticals-present-interim-data-200800399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRVS","SID","BK4568","BK4006","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":10,"totalSize":306,"code":"91000000","status":"200"}]}}